- Home
- FND vs IBRX Comparison
FND vs IBRX Comparison
Compare FND & IBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FND | IBRX |
|---|---|---|
| Founded | 2000 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | RETAIL: Building Materials | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.4B | 8.4B |
| IPO Year | 2014 | 2015 |
Fundamental Metrics
Financial Performance| Metric | FND | IBRX |
|---|---|---|
| Price | $51.77 | $7.15 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 16 | 7 |
| Target Price | ★ $78.81 | $12.57 |
| AVG Volume (30 Days) | 2.0M | ★ 27.0M |
| Earning Date | 04-30-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 1.05 | ★ 38.71 |
| EPS | ★ 1.92 | N/A |
| Revenue | ★ $4,684,088,000.00 | $113,288,000.00 |
| Revenue This Year | $7.56 | $88.57 |
| Revenue Next Year | $7.78 | $146.98 |
| P/E Ratio | $26.11 | ★ N/A |
| Revenue Growth | 5.12 | ★ 668.31 |
| 52 Week Low | $49.89 | $1.83 |
| 52 Week High | $92.41 | $12.43 |
Technical Indicators
Market Signals| Indicator | FND | IBRX |
|---|---|---|
| Relative Strength Index (RSI) | 30.04 | 43.48 |
| Support Level | N/A | $2.25 |
| Resistance Level | $64.23 | $8.28 |
| Average True Range (ATR) | 2.39 | 0.83 |
| MACD | -0.72 | -0.20 |
| Stochastic Oscillator | 13.85 | 21.00 |
Price Performance
Historical ComparisonAbout FND Floor & Decor Holdings Inc.
Floor & Decor Holdings Inc operates as a specialty retailer in the hard surface flooring market. Its stores offer a range of tile, wood, laminate, and natural stone flooring products, as well as decorative and installation accessories at everyday low prices. It appeals to a variety of customers including professional installers, commercial businesses, Do It Yourself (DIY) customers, and customers who buy the products for professional installation. Geographically, the group has a presence in the United States region and also offers its product through an e-commerce site. The company segments include retail segment and others.
About IBRX ImmunityBio Inc.
ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.